Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection

Journal of Hepatology

Volumn 54, Issue 2, 2011, Pages 201-208

  Schulte, I ^a   Hitziger, T ^a   Giugliano, S ^a   Timm, J ^a   Gold, H ^b   Heinemann, F M ^a   Khudyakov, Y ^c   Strasser, M ^d   Konig C ^e   Castermans, E ^f   Mok, J Y ^g   Van Esch, W J E ^g   Bertoletti, A ^h   Schumacher, T N ^f   Roggendorf, M ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Referat für Gesundheit und Umwelt ^*  (Germany)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e Public Health Authority   (Austria)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g CENTRAL LABORATORY   (Netherlands)

^h AGENCY FOR SCIENCE   (Singapore)

Author keywords

Cellular immune response; Epitope characterization; Hepatitis A virus

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYPROTEIN; SYNTHETIC PEPTIDE; VIRUS RNA;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PEPTIDE SYNTHESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS HEPATITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HLA-A2 ANTIGEN; HUMANS; MALE; MIDDLE AGED;

EID: 78751567759     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.07.010     Document Type: Article

References (21)

1. L.V.S. Asher, L.N. Binn, T.L. Mensing, R.H. Marchwicki, R.A. Vassel, and G.D. Young Pathogenesis of hepatitis A in orally inoculated owl monkeys J Med Virol 47 1995 260 268
2. A.H. Bakker, R. Hoppes, C. Linnemann, M. Toebes, B. Rodenko, and C.R. Berkers Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 Proc Natl Acad Sci USA 105 2008 3825 3830
3. W.A. Bower, O.V. Nainan, X. Han, and H.S. Margolis Duration of viremia in hepatitis A virus infection J Infect Dis 182 2000 12 17
4. J.I. Cohen, J.R. Ticerhurst, R.H. Purcell, A.J. Buckler-White, and B.M. Baroudy Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses J Virol 61 1987 50 59
5. J. Cristina, and M. Costa-Mattioli Genetic variability and molecular evolution of hepatitis A virus Virus Res 127 2007 151 157
6. D. Daniels, S. Grytdal, and A. Wasley CDC. Surveillance for acute viral hepatitis - United States 2007 MMWR Surveill Summ 58 2009 1 27
7. V. Fensterl, D. Grotheer, I. Berk, S. Schlemminger, A. Vallbracht, and A. Dotzauer Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon J Virol 79 2005 10968 10977
8. C. Frank, J. Walter, M. Muehlen, A. Jansen, U. van Treeck, and A.M. Hauri Major outbreak of hepatitis A associated with orange juice among tourists 2004 Emer Infect Dis 13 2007 156 158
9. K. Fujiwara, O. Yokosuka, F. Imazeki, M. Miki, K. Suzuki, and K. Okita Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities J Gastroenterol 42 2007 560 566
10. D.N. Garboczi, D.T. Hung, and D.C. Wiley HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides Proc Natl Acad Sci USA 89 1992 3429 3433
11. K.H. Jacobsen, and J.S. Koopman Declining hepatitis A seroprevalence: a global review and analysis Epidemiol Infect 132 2004 1005 1022
12. M. Kulka, M.S. Calvo, D.T. Ngo, S.Q. Wales, and B.B. Goswami Activation of the 2-5OAS/RNase L pathway in CBV1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression Virology 388 2009 169 184
13. A. Martin, and S.M. Lemon Hepatitis A virus: from discovery to vaccines Hepatology 43 2006 164 172
14. D. Paulmann, T. Magulski, R. Schwarz, L. Heitmann, B. Flehmig, and A. Vallbracht Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation J Gen Virol 89 2008 1593 1604
15. G. Rezende, A.M. Roque-Afonso, D. Samuel, M. Gigou, E. Nicand, and V. Ferre Viral and clinical factors associated with the fulminant course of hepatitis A infection Hepatology 38 2003 613 618
16. B. Rodenko Generation of peptide-MHC class I complexes through UV-mediated ligand exchange Nat Protoc 1 2006 1120 1132
17. D. Schmid, R. Fretz, G. Buchner, C. König, H. Perner, and R. Sollak Foodborne outbreak of hepatitis A in Austria Eur J Clin Microbiol Infect Dis 28 2009 385 391
18. M. Toebes Design and use of conditional MHC class I ligands Nat Med 12 2006 246 251
19. A. Vallbracht, P. Gabriel, K. Maier, F. Hartmann, H.J. Steinhardt, and C. Müller Cell-mediated cytotoxicity in hepatitis A virus infection Hepatology 6 1986 1308 1314
20. A. Vallbracht, K. Maier, Y.D. Stierhof, K.H. Wiedmann, B. Flehmig, and B. Fleischer Liver-derived cytotoxic T cells in hepatitis A virus infection J Infect Dis 160 1989 209 217
21. + T-cell epitopes shared among group B enteroviruses J Gen Virol 89 2008 2090 2097